Sort
30,917 grants matching “tumor microenvironment”
Tumor Microenvironment in Cancer Progression
$515,673Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
$515,673Rosandra Kaplan · Division Of Basic Sciences - Nci · ZIA · FY2016 · CA
BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERSTASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND LYNCH SYNDROME-ASSOCIA
$515,612Margie L. Clapper · Research Inst Of Fox Chase Can Ctr · N01 · FY2024 · CA
Exploring the Function of MHC-II/Lag3 Axis in Brain Metastasis to Develop Novel Therapeutic Strategies
$515,611Dihua Yu · University Of Tx Md Anderson Can Ctr · R01 · FY2023 · CA
Image Biomarker Development for TreatmentEfficacy of Prostate Cancer to the Bone
$515,425Brian D. Ross · University Of Michigan At Ann Arbor · R01 · FY2011 · CA
Innovative Approaches to Treat Duchenne Muscular Dystrophy Using iPSC-Derived Muscle Progenitors
$515,417Yao Liang Tang · Augusta University · R01 · FY2020 · AR
The role of collagen and its signaling mechanisms in glioma progression and invasion.
$515,373Pedro R Lowenstein · University Of Michigan At Ann Arbor · R01 · FY2023 · NS
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$515,359Steven Mark Albelda · University Of Pennsylvania · P01 · FY2021 · CA
Project 2 - Preclinical studies: Overcoming tumor heterogeneity
$515,359Steven Mark Albelda · University Of Pennsylvania · P01 · FY2020 · CA
Engaging immunosuppressive myeloid cells in the TME for the treatment of pancreatic cancer
$515,333Jeffrey Victor Ravetch · Rockefeller University · R01 · FY2024 · CA
CAREER: A Biomanufactured Platform for Modulating Immune Cell-Bacteria Interactions in the Tumor Microenvironment
$515,223Bahareh Behkam · Virginia Polytechnic Institute And State University · · FY2015 · ENG
Targeted therapeutics for ovarian cancer and its microenvironment - treatment and theoretical modeling
$515,198Gabriel Lopez-Berestein · University Of Tx Md Anderson Can Ctr · U01 · FY2017 · CA
LEVERAGING REACTIVATION OF TISSUE-RESIDENT MEMORY T CELLS IN THE TUMOR MICROENVIRONMENT FOR ONCOLYTIC VIROTHERAPY
$515,187Regents Of The University Of Minnesota · · FY2025 · Defense Health Agency
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2023 · NS
Hydrogen sulfide functions as a tumor suppressor in glioblastoma
$515,147Christopher Michael Hine · Cleveland Clinic Lerner Com-Cwru · R01 · FY2025 · NS
Antigen-Presenting Cell Control of CD8+ T Cell Exhaustion in Cancer
$515,141Ming Li · Sloan-Kettering Inst Can Research · R01 · FY2024 · CA
Tumor-promoting and tumor-suppressive roles of Hepatic Stellate Cell Subpopulations in NASH-HCC
$515,123Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2022 · CA
Targeting the gut microbiome to inhibit melanoma lymph node metastases
$515,112Jennifer A. Wargo · University Of Tx Md Anderson Can Ctr · R01 · FY2025 · CA
Defining bone ecosystem effects on metastatic prostate cancer evolution and treatment response using an integrated mathematical modeling approach
$515,073Conor C Lynch · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2021 · CA
Enhancing the efficacy of androgen signaling inhibitors in prostate cancer
$515,060Xiaoqi Liu · University Of Kentucky · R01 · FY2025 · CA
Host-Tumor Cell Interactions in Myeloma: Therapeutic Applications
$514,934Kenneth C Anderson · Dana-Farber Cancer Inst · P01 · FY2009 · CA
Fatty Acid Metabolic Regulation of Anti-Tumor Immunity Against Irradiated Glioblastoma
$514,923Claire Isabelle Vanpouille-Box · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · NS
Manipulating normal estrogen physiology as a therapeutic approach in cancer
$514,902Donald P McDonnell · Duke University · R01 · FY2024 · CA
Preclinical microphysiological tumor models for nuclear medicine
$514,734Guillem Pratx · Stanford University · R01 · FY2025 · CA
Sexual Dimorphism in T Cell Exhaustion and Bladder Cancer
$514,697Zihai Li · Cedars-Sinai Medical Center · P01 · FY2025 · CA